NET PROFIT (x1000 DKK)
EMPLOYEES
Enza Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-5,981
|
-5,777
|
-5,673 |
EBITDA |
-5,570
|
-5,365
|
-5,255 |
Total assets |
3,717
|
3,677
|
4,243 |
Current assets |
1,548
|
1,211
|
1,237 |
Current liabilities |
1,190
|
693
|
673 |
Equity capital |
2,527
|
2,984
|
3,570 |
- share capital |
185
|
184
|
201 |
Employees (average) |
5
![]() |
5
![]() |
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
81.2%
|
84.1% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-160.9%
|
-157.1%
|
-133.7% |
Current ratio |
130.1%
|
174.7%
|
183.8% |
Return on equity (ROE) |
-236.7%
|
-193.6%
|
-158.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.